|
HY-108831A-1mg
|
MedChemexpress LLC
|
Natalizumab (Solution) [CAS 189261-10-7]
|
|
|
|
|
HY-108831A-10mg
|
MedChemexpress LLC
|
Natalizumab (Solution) [CAS 189261-10-7]
|
|
|
|
|
HY-108831A-25mg
|
MedChemexpress LLC
|
Natalizumab (Solution) [CAS 189261-10-7]
|
|
|
|
|
HY-108831A-5mg
|
MedChemexpress LLC
|
Natalizumab (Solution) [CAS 189261-10-7]
|
|
|
|
|
HY-108831-10mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-108831-25mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-108831-5mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99037-1mg
|
MedChemexpress LLC
|
Nipocalimab [CAS 2211985-36-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99037-5mg
|
MedChemexpress LLC
|
Nipocalimab [CAS 2211985-36-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99756-1mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99756-10mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99756-5mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99764-1mg
|
MedChemexpress LLC
|
Odesivimab [CAS 2135632-30-1]
|
|
|
|
|
HY-P99764-10mg
|
MedChemexpress LLC
|
Odesivimab [CAS 2135632-30-1]
|
|
|
|
|
HY-P99764-5mg
|
MedChemexpress LLC
|
Odesivimab [CAS 2135632-30-1]
|
|
|
|
|
HY-P9950-1mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P9950-5mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99770-1mg
|
MedChemexpress LLC
|
Omodenbamab [CAS 2241724-48-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99770-10mg
|
MedChemexpress LLC
|
Omodenbamab [CAS 2241724-48-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99770-5mg
|
MedChemexpress LLC
|
Omodenbamab [CAS 2241724-48-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108044-5mg
|
MedChemexpress LLC
|
ONO-5334 [CAS 868273-90-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-108044-1mL
|
MedChemexpress LLC
|
ONO-5334 [CAS 868273-90-9] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P99211-1mg
|
MedChemexpress LLC
|
Otelixizumab [CAS 881191-44-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P99211-10mg
|
MedChemexpress LLC
|
Otelixizumab [CAS 881191-44-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P99211-5mg
|
MedChemexpress LLC
|
Otelixizumab [CAS 881191-44-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
